"Manage Diabetes with VOGLIGOLD G3 M0.3 Combination"

May 24, 2024

VOGLIGOLD G3 M0.3 

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

Introduction

The combination of Voglibose 0.3 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg is a powerful medication regimen used to manage type 2 diabetes. This combination leverages the benefits of an alpha-glucosidase inhibitor, a sulfonylurea, and a biguanide to provide comprehensive blood sugar control, reducing the risk of diabetes-related complications.

Uses of Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

  1. Blood Sugar Control: VOGLIGOLD G3 M0.3  effectively lowers blood sugar levels in patients with type 2 diabetes.
  2. Reduction of Postprandial Glucose: Voglibose helps reduce the rise in blood sugar after meals by inhibiting carbohydrate absorption.
  3. Insulin Secretion Enhancement: Glimepiride stimulates the pancreas to release more insulin, improving blood sugar control.
  4. Insulin Sensitivity Improvement: Metformin enhances insulin sensitivity, helping the body use insulin more effectively.

How Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg Works

  • Voglibose: An alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the intestines, leading to a lower rise in blood sugar levels after meals.
  • Glimepiride: A sulfonylurea that stimulates the pancreas to produce and release more insulin, which helps lower blood sugar levels.
  • Metformin: A biguanide that decreases glucose production in the liver, improves insulin sensitivity, and enhances glucose uptake by muscles.

Dosage and Administration

This combination medication is typically taken once or twice daily, with meals. It is essential to follow your doctor’s instructions regarding dosage and timing. Regular monitoring of blood sugar levels is necessary to ensure the medication is working effectively.

Side Effects

Common side effects include gastrointestinal issues such as nausea, diarrhea, and abdominal discomfort. Other side effects can include hypoglycemia (low blood sugar), dizziness, and headache. Serious side effects, although rare, can include lactic acidosis (a buildup of lactic acid in the blood) and severe allergic reactions. If you experience any severe or unusual symptoms, contact your healthcare provider immediately.

Precautions

  • Medical History: Inform your doctor if you have a history of kidney or liver problems, heart disease, or other medical conditions.
  • Drug Interactions: This medication can interact with other drugs. Provide your healthcare provider with a complete list of your medications.
  • Pregnancy and Breastfeeding: Consult your doctor if you are pregnant or breastfeeding before starting this medication.

Conclusion

The combination of Voglibose 0.3 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg is highly effective for managing type 2 diabetes. With proper use and regular medical supervision, patients can achieve significant improvements in their blood sugar control and overall health.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

 

SHARE WITH